Plus: DPP4 inhibitors and COVID-19; breastfeeding and type 2; carb quality
Can't see the images? View as webpage.
Facebook
Twitter
LinkedIn
To ensure that you never miss an issue, please whitelist us.

June 13, 2020 : Issue #1046

TOP STORIES - Diabetes News & Research

A Link Between ESRD and Low BMI

Breastfeeding Key To Preventing T2DM

Could a Diabetes Medication Affect COVID-19 Outcomes?
Letter from the Editor

As the US continues to relax stay at home policies and social distancing, there has been an increase in diagnosed Covid-19 cases. Here in Florida the past two days have seen the highest counts of new positives since we started collecting data back in March. And it looks like it is bound to get worse before it gets better.

I am not saying that wearing a mask guarantees you won’t get Covid-19, but when you walk into a store and only 5% of the patrons have a mask on, you have to think the worst.

There are a lot of companies looking for a cure and last Saturday our good friend, Joe Graedon, from the People's Pharmacy, had an epidemiologist speaking about the rush to find current medications that may be able to be re-purposed to help Covid patients.

Interestingly enough, our current intern,Jacob Roberts, PharmD Candidate 2021 of University of Colorado Denver Skaggs School of Pharmacy and Pharmaceutical Sciences, was looking for diabetes medications that may be re-purposed and found that DPP4-Inhibitors may hold promise in the near future. Check out the article here.

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief


Doctor's Option
lab test products include rapid tests and CLIA certified fingerstick lab tests.

Rapid tests offer immediate test results to provide doctors with point of care test results in as little as 90 seconds.

Fingerstick lab tests provide CLIA certified lab accurate results. Each fingerstick lab test collection kit comes with a prepaid postage return envelope and everything you need to obtain and collect your fingerstick blood sample in a 510K FDA approved device.

Fingerstick lab tests are great for people who want to monitor their blood sugar, cholesterol, lipids and other important bio-markers at home or on the go.

Visit Doctor's Option

TOP STORIES - Diabetes News and Research

A Link Between ESRD and Low BMI
Study of BMI and ESRD suggests obesity may provide a health benefit when it comes to end-stage renal disease.
READ MORE
Breastfeeding Key To Preventing T2DM
Prolonged lactation may reduce the risk for women with a history of gestational diabetes.
READ MORE
Could a Diabetes Medication Affect COVID-19 Outcomes?
Research into the interaction of DPP4 and coronavirus may be a step toward a cure.
READ MORE

Fact: The Quality of Carbohydrates Matters in Reducing Diabetes Risk


Consuming high-quality carbohydrates, particularly whole grains, lowered the risk for type 2 diabetes, according to data presented at Nutrition 2020 Live Online, June 1-4, 2020. The results were from analysis of dietary data for three large prospective U.S. cohorts, encompassing  more than 200,727 participants who were enrolled in the Nurses’ Health Study, Nurses’ Health Study II, and Health Professionals Follow-up Study. Collectively, their analysis represented almost 4 million years of follow-up. The researchers identified 11,872 documented cases of type 2 diabetes in their analysis. They found that replacing 5% of energy from saturated fat with 5% of energy from low-quality carbohydrates — refined grains, sugary foods, and potatoes — was associated with a higher type 2 diabetes risk  (HR = 1.05; 95% CI, 1-1.09). However, substituting 5% of energy from saturated fat with high- quality carbohydrates, such as whole-grain bread, brown rice, rye, barley, and quinoa, was associated with a lower type 2 diabetes risk (HR = 0.93; 95% CI, 0.87-0.99).  

Further, the isocaloric substitution of other macronutrients with low-quality carbohydrates was not associated with type 2 diabetes risk. Conversely, isocaloric substitution of high-quality carbohydrates was associated with lower type 2 diabetes risk when the replacement nutrient was monounsaturated fat (HR = 0.88; 95% CI, 0.83-0.94), animal protein (HR = 0.88; 95% CI, 0.83-0.93), vegetable protein (HR = 0.9; 95% CI, 0.84-0.96), trans fat (HR = 0.9; 95% CI, 0.85-0.97) and polyunsaturated fat (HR = 0.92; 95% CI, 0.86-0.98.  

“When individuals consume a low-fat diet, the replacement nutrient is almost always low quality or refined carbohydrates that this study shows to be associated with a higher risk for type 2 diabetes,” noted the researchers; “The quality of carbohydrate matters.” 

Journal of Nutrition 2020     Diabetologia

Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters:

Stephanie Anderson, PharmD Candidate 2021, Skaggs School of Pharmacy and Pharmaceutical Sciences

Antonio Bess, Pharm D Candidate, Florida Agricultural & Mechanical University School of Pharmacy

George McConnell, PharmD. Candidate, LECOM School of Pharmacy

Jacob Roberts, PharmD Candidate 2021 of University of Colorado Denver Skaggs School of Pharmacy and Pharmaceutical Sciences 

Chardae Whitner PharmD Candidate L|E|C|O|M Bradenton School of Pharmacy

 About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.
Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com
Facebook
Twitter
LinkedIn
©2020 HIPER, LLC. All rights reserved.

This email was sent by eHealthcare Solutions on behalf of:
Diabetes In Control
810 Bear Tavern Rd, Suite 102
Ewing, NJ, 08628, United States


DiabetesInControl.com | Contact Us
Subscription Center | Update Profile
Unsubscribe